Cite

HARVARD Citation

    Schlander, M. et al. (2015). Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe. Expert review of pharmacoeconomics & outcomes research. pp. 171-179. [Online]. 
  
Back to record